TD Cowen analyst Phil Nadeau maintained a Buy rating on Atara Biotherapeutics (ATRA – Research Report) yesterday. The company’s shares closed last Friday at $6.90. See what stocks are ...

Atara Biotherapeutics (ATRA) came out with a quarterly loss of $1.19 per share versus the Zacks Consensus Estimate of a loss of $3.82. This compares to loss of $14 per share a year ago.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Crawford Area Transportation Authority (CATA) will be offering a new service in Cambridge Springs. Every Monday and Tuesday starting next week, CATA will provide an on-demand mobility service ...

After hours: March 27 at 4:00:10 PM EDT Vertex Baseline Delta ...

Jim Chee deals with his dark past when they are called by the Sheriff. Two 14-year-old local boys, Ernesto Cata and George Bowlegs, are missing, and Sheriff Sena seeks Leaphorn and Chee's assistance ...